Project Grant F32AI186285
Award Date
12/13/24
Completion Date
10/31/27
Dollars Obligated
$149K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $162,000 in funding to the Rector & Visitors of the University of Virginia (UVA) from September 1, 2024 to August 31, 2026. The project aims to characterize a Type VII secretion system (T7SS) in Group B Streptococcus (GBS) and investigate its role in virulence and immune response. Key objectives include...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under CFDA Program 93.855 Allergy and Infectious Diseases Research, provides $242,250 to The Methodist Hospital Research Institute (HMRI) to evaluate the translational potential of two novel strategies, salivabactin and an engineered probiotic, to treat or prevent Group B Streptococcus (GBS) infections in preclinical mouse models. The goal is to fully assess the efficacy of these therapeutic and...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $483,000.00 to Case Western Reserve University to conduct research on defining the role of single-cell heterogeneity in bacterial vaginosis (BV). The overarching goal is to identify aspects of diversity that impact BV and provide insights into new strategies for prevention, treatment, and diagnosis. The...
This Project Grant award of $222,750.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research by the University of Alabama at Birmingham (UAB) to investigate the novel functions of the Fc fragment of IgG binding protein (FcGBP) in the colon mucus layer and its impact on the gut microbiome. The research aims to determine how FcGBP contributes to the glycosylation and sialylation of the...
This federal Project Grant award, totaling $189,150.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant aims to elucidate the molecular mechanisms of the Streptococcus pneumoniae high temperature requirement A (HtrA) enzyme, which is a critical virulence factor for bacterial infection. Specifically, the research will investigate the structural rearrangements and dynamics of the...
This federal Project Grant award of $837,644 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to develop effective anti-microbial vaccines targeting the poly-β-(1-6)-N-acetylglucosamine (PNAG) virulence factor. The research team from Michigan State University will establish new methodologies to synthesize a comprehensive library of PNAG oligosaccharides with varied amine/acetylation...
This federal Project Grant award, titled "EXPLOITING THE MICROBIOTA-STROMAL CELL AXIS FOR MICROBIOTA-TARGETED MEDICINE", is funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The $466,500 award will support research to identify gut stromal cell populations and microbial components that influence B-cell development and antibody production in response to vaccination, with the goal of...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $189,150.00 to the University of Colorado-Denver to conduct research aimed at identifying new regulators of outer membrane vesicle (OMV) entry into macrophages. The goal is to bridge the knowledge gap on the upstream stage of OMV entry into macrophages, which can trigger an inflammatory form of cell death. The research...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $152,656 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Colorado-Denver. The grant, titled "Synaptopodin and Its Role in Shigella flexneri Intercellular Spread," will fund research to investigate the molecular mechanisms by which the protein synaptopodin promotes the ability of the Shigella bacteria to spread between cells, a critical process for...
This Project Grant award of $696,544, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 Allergy and Infectious Diseases Research, supports research to investigate the contractile attachment mechanisms of the ventral disc in the parasite Giardia lamblia. The research aims to leverage new CRISPR-based genetic tools and live imaging approaches to evaluate how specific disc structural elements generate the forces underlying Giardia's attachment to the...